Johnson & Johnson is primarily active in the healthcare industry. With a diverse range of products, the company operates in multiple sectors such as pharmaceuticals, medical devices, and consumer health. Johnson & Johnson is renowned for its comprehensive portfolio that includes prescription drugs, over-the-counter medications, surgical equipment, contact lenses, and personal care products. Being a global leader, Johnson & Johnson's presence extends across various healthcare segments, enabling it to contribute significantly to advancing medical solutions and enhancing overall well-being.

Some of the main competitors of Johnson & Johnson in the market include Pfizer Inc., Merck & Co., Inc., and Roche Holding AG.

Johnson & Johnson is a multinational healthcare company that was founded in 1886. It has a rich history and has become a leader in the pharmaceutical, medical devices, and consumer healthcare sectors. With over 130 years of experience, Johnson & Johnson has continually focused on delivering innovative solutions to improve the health and well-being of people around the world. The company has grown through strategic acquisitions and partnerships, expanding its product portfolio and global presence. Johnson & Johnson's commitment to research and development, along with its dedication to ethical business practices, have made it a trusted name in the healthcare industry.

Some significant milestones achieved by Johnson & Johnson include the development of innovative medical treatments and breakthrough pharmaceutical products. Throughout its history, the company has also played a crucial role in the advancement of healthcare technology and the improvement of patient care. Johnson & Johnson has consistently demonstrated its commitment to quality and safety, earning a reputation as a trusted global healthcare leader. With a strong focus on research and development, the company has introduced numerous life-saving and life-enhancing solutions to address a wide range of medical needs. Through its dedication to innovation and excellence, Johnson & Johnson continues to shape the future of healthcare.

Johnson & Johnson is primarily present in several countries and regions worldwide. The company has a significant presence in the United States, where it is headquartered, and it operates in countries across North America, Europe, Asia Pacific, and Latin America. Some prominent regions where Johnson & Johnson operates include Canada, Germany, France, Japan, Australia, Brazil, and China. With its diverse portfolio of healthcare products and services, Johnson & Johnson continues to expand its presence globally, serving the healthcare needs of people in numerous countries and regions.

Johnson & Johnson is a renowned global healthcare company that upholds strong values and a clear corporate philosophy. With a commitment to improving the well-being of people worldwide, the company focuses on three fundamental principles: caring for the world, keeping customers at the center, and cherishing employees. Johnson & Johnson values integrity, innovation, diversity, and collaboration, consistently striving to deliver high-quality products and solutions. With a customer-centric approach, the company endeavors to create lasting relationships and enhance experiences. By fostering a supportive work environment and promoting professional growth, Johnson & Johnson ensures its employees play a vital role in achieving its mission.

Analysts currently set an average price target of 234,56 USD for the Johnson & Johnson stock (median: 241,74 USD), implying −9,5 % versus the latest price. The consensus is based on 32 analyst ratings.

Johnson & Johnson Ciljne cijene analitičara 2026

32 analysts currently rate the Johnson & Johnson stock: 19 recommend buying, 13 holding and 0 selling. For 2026, analysts expect Johnson & Johnson to generate revenue of 101,27 milijardi USD and earnings per share of 11,64 USD.

Johnson & Johnson Ciljne cijene analitičara 2026

Converted at the current exchange rate, the Johnson & Johnson share trades at 224,50 EUR (259,26 USD).

The Johnson & Johnson share (JNJ) is listed on 12 stock exchanges, including: NYSE (JNJ), XETRA (JNJ.DE), Frankfurt (JNJ.F), München (JNJ.MU), Stuttgart (JNJ.SG), Düsseldorf (JNJ.DU), Berlin (JNJ.BE), Hamburg (JNJ.HM).

Johnson & Johnson is one of the largest healthcare companies in the world. The company was founded in 1886 and is based in New Brunswick, New Jersey. With a wide portfolio of products and services, Johnson & Johnson is active in the consumer goods, medical technology, and pharmaceutical sectors. Consumer Goods: Johnson & Johnson is best known for its baby care products, such as diapers and wipes. The company also offers a wide range of other products, including personal care, wound healing, and pain relief products. Medical Technology: As a global leader in medical devices and instruments, Johnson & Johnson provides solutions for various areas of the medical field. In orthopedics, for example, the company offers implants for a variety of joints and bones. In medical imaging, Johnson & Johnson has a diverse range of devices that can be used for diagnosis and treatment. Pharmaceuticals: Johnson & Johnson is also active in the pharmaceutical business. The company is a global leader in the development and marketing of prescription drugs. In the field of oncology, for example, Johnson & Johnson offers various medications for the treatment of cancer. The company is also involved in neurology and immunology, offering a wide range of medications. Innovative Technologies: Johnson & Johnson heavily invests in innovative technologies to improve treatment options for patients. Examples of this include the "CaringCrowd" crowdfunding platform and the "Janssen Health EMEA Innovation Center," a platform for start-ups and companies focusing on groundbreaking innovations in healthcare. Research and Development: Research and development is a crucial aspect of Johnson & Johnson's business success. The company invests significant amounts each year in the research and development of new products and technologies. The goal is to develop products that meet the needs of patients and address various diseases and conditions. Johnson & Johnson also conducts extensive clinical studies to ensure the safety and efficacy of its products. Conclusion: Johnson & Johnson has a diverse range of products and services. The company is a leading provider in consumer goods, medical technology, and pharmaceuticals. It heavily invests in innovative technologies and research and development to offer treatment options to patients worldwide that meet the highest standards in terms of efficacy and safety. The output answer: Johnson & Johnson is a global healthcare company that offers a wide range of consumer goods, medical technology, and pharmaceutical products. It invests in innovative technologies and research and development to provide effective and safe treatment options for patients worldwide.

Prihod od očekivane od Johnson & Johnson iznosi 101,27 milijardi USD. Ova brojka temelji se na trenutnim financijskim podacima i odražava poslovnu uspješnost poduzeća.

Dobit od očekivane od Johnson & Johnson iznosi 28,38 milijardi USD. Neto dobit pokazuje profitabilnost poduzeća nakon odbitka svih troškova.

Omjer cijene i zarade (KGV) od Johnson & Johnson trenutno je 22,28. KGV uspoređuje trenutnu cijenu dionice sa zaradom po dionici i pomaže ulagačima da procijene vrednovanje dionice Johnson & Johnson.

Omjer cijene i prihoda (KUV) od Johnson & Johnson trenutno je 6,24. KUV uspoređuje tržišnu kapitalizaciju s godišnjim prihodom i služi kao pokazatelj vrednovanja dionice Johnson & Johnson.

Eulpool Quality Score za Johnson & Johnson je 6/10.

ISIN od Johnson & Johnson je US4781601046. ISIN (International Securities Identification Number) je globalno jedinstvena identifikacija za vrijednosne papire.

WKN od Johnson & Johnson je 853260. WKN (Wertpapierkennnummer) je šestoznačni njemački broj za identifikaciju vrijednosnih papira.

Ticker od Johnson & Johnson je JNJ. Simbol tickera koristi se za trgovanje dionicama Johnson & Johnson na burzi.

Tijekom proteklih 12 mjeseci, Johnson & Johnson je isplatio dividendu od 5,14 USD . To odgovara prinosu dividende od oko 1,98 %. Za nadolazeće 12 mjeseci, Johnson & Johnson se očekuje da isplati dividendu od 5,56 USD.

Sadašnja dividendna randita Johnson & Johnson iznosi 1,98 %.

Johnson & Johnson isplaćuje dividendu, distribuiranu u mjesecima , , , .

Johnson & Johnson je isplaćivao dividende svake godine u proteklih 62 godina.

Za nadolazeće 12 mjeseci očekuju se dividende u vrijednosti od 5,56 USD. To odgovara prinosu dividende od 2,16 %.

Johnson & Johnson je dodijeljen sektoru 'Zdravstvo'.

U godini 2025, Johnson & Johnson je isplatio 4,91 USD kao dividende.

Dividende od Johnson & Johnson distribuiraju se u USD.